Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052521
Filing Date
2020-11-09
Accepted
2020-11-09 16:20:04
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ccxi-10q_20200930.htm   iXBRL 10-Q 2394416
2 EX-10.1 ccxi-ex101_729.htm EX-10.1 613735
3 EX-10.2 ccxi-ex102_174.htm EX-10.2 24576
4 EX-31.1 ccxi-ex311_6.htm EX-31.1 9416
5 EX-31.2 ccxi-ex312_10.htm EX-31.2 9366
6 EX-32.1 ccxi-ex321_11.htm EX-32.1 6175
7 EX-32.2 ccxi-ex322_7.htm EX-32.2 6282
8 GRAPHIC gwmue4nwpsku000002.jpg GRAPHIC 2854
9 GRAPHIC gwmue4nwpsku000001.jpg GRAPHIC 1993
  Complete submission text file 0001564590-20-052521.txt   9418412

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20200930.xsd EX-101.SCH 54330
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20200930_cal.xml EX-101.CAL 57223
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20200930_def.xml EX-101.DEF 140816
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20200930_lab.xml EX-101.LAB 413560
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20200930_pre.xml EX-101.PRE 305080
15 EXTRACTED XBRL INSTANCE DOCUMENT ccxi-10q_20200930_htm.xml XML 1869116
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 201297949
SIC: 2834 Pharmaceutical Preparations